InflammopharmacologyHumansParkinson DiseaseAnimalsNeuroprotective AgentsSignal Transduction
Asperuloside: an emerging therapeutic candidate for Parkinson's disease through molecular mechanistic insights.
Shiv Kumar Kushawaha, Kanika Vashisht, Himanshu Kumar, Mahendra Singh Ashawat, Ashish Baldi
Published: 202510.1007/s10787-025-01981-x
Abstract
Parkinson's disease is a progressively debilitating neurodegenerative disorder marked by the loss of dopaminergic neurons, with chronic neuroinflammation and oxidative stress playing pivotal roles in its pathogenesis. While current therapeutic regime…
Preview only. Read the full abstract at the source